Who is sponsoring NCT03239262?

NCT03239262 is sponsored by University Hospital Ostrava.

What drugs are being tested in NCT03239262?

Interventions in NCT03239262: Concomitant Mapping and Radiofrequency Ablation, No intervention.

What condition does NCT03239262 study?

NCT03239262 studies Mitral Valve Disease, Coronary Artery Disease, Tricuspid Valve Disease, Aortic Valve Disease, Atrial Fibrillation.

Is NCT03239262 still recruiting?

NCT03239262 is currently completed. Last updated 4 August 2017.

Last reviewed 2017-08-04 · How we verify

NCT03239262

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation

Completed NA Last updated 4 August 2017

What this trial tests

NA trial testing Concomitant Mapping and Radiofrequency Ablation in Mitral Valve Disease in 100 participants. Completed in 28 February 2016.

Timeline

1 July 2012

Primary endpoint
31 January 2016

28 February 2016

Quick facts

Lead sponsor	University Hospital Ostrava
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 July 2012
Primary completion	31 January 2016
Estimated completion	28 February 2016

Drugs / interventions tested

Concomitant Mapping and Radiofrequency Ablation
No intervention

Conditions studied

Mitral Valve Disease — all drugs for Mitral Valve Disease →
Coronary Artery Disease — all drugs for Coronary Artery Disease →
Tricuspid Valve Disease — all drugs for Tricuspid Valve Disease →
Aortic Valve Disease — all drugs for Aortic Valve Disease →

Sponsor

University Hospital Ostrava

Who can join

Adults 40 to 80, any sex, with Mitral Valve Disease or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study was to investigate, whether enhancement of left atrial cryoablation by ablation of the autonomic nervous system of left atrium leads to influencing the outcomes of surgical treatment of atrial fibrillation in patients with structural heart disease undergoing open-heart surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Neuromodulatory Approaches for Atrial Fibrillation Ablation.
Rodríguez-Mañero M, Martínez-Sande JL, García-Seara J, González-Ferrero T, et al · · 2021 · cited 1× · PMID 35024055 · DOI 10.15420/ecr.2021.05

Verify or expand the search:

Other recruiting trials for Mitral Valve Disease

Currently open trials in the same condition.

NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
NCT06557616 — Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation · recruiting
NCT06235385 — European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study · recruiting
NCT04916535 — Prospective Multicenter Study on Mitral Annular Disjunction · NA · active not recruiting
NCT04954404 — Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients With Mitral Valve Disease (TORCH-M) · NA · recruiting

Other University Hospital Ostrava trials

Trials by the same sponsor.

NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07041086 — Prehospital ECPR in Moravia Silesia Region · recruiting
NCT07009652 — Optimization of Transport and Use of a Mobile ECMO Team in Patients With Sudden Cardiac Arrest in the Moravian-Silesian · recruiting
NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03239262 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Ostrava
Last refreshed: 4 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03239262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing